home / stock / gh / gh articles
The U.S. stock rally faces the risk of stalling, as index futures point to a lower opening on Wednesday. The Dow Industrials and the Nasdaq Composi...
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he remains a buyer of SoFi Technologies, Inc. (NASDAQ: SOFI). "Rememb...
Darya Chudova, Chief Technology Officer at Guardant Health (NASDAQ:GH), reported a large exercise of company stock options on November 16, accordin...
Guardant Health Inc (NASDAQ: GH) reported Q3 revenue of $143 million, up 22% Y/Y, beating the consensus of $137.37 million. Precision onc...
In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVI...
News, Short Squeeze, Breakout and More Instantly...
2024-06-21 23:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Upgraded gene panel on tissue genomic profiling test covers 498 biomarkers, including guideline-recommended genes Operational improvements streamline workflow and shorten time to results Upgraded test covered by Medicare for comprehensive genomic profiling of all advanced solid tu...
2024-06-04 07:00:06 ET Kyle Mikson from Canaccord Genuity issued a price target of $38.00 for GH on 2024-06-04 05:20:00. The adjusted price target was set to $38.00. At the time of the announcement, GH was trading at $27.41. The overall price target consensus is at $58.2...